Cargando…
Identification of Toyocamycin, an agent cytotoxic for multiple myeloma cells, as a potent inhibitor of ER stress-induced XBP1 mRNA splicing
The IRE1α-XBP1 pathway, a key component of the endoplasmic reticulum (ER) stress response, is considered to be a critical regulator for survival of multiple myeloma (MM) cells. Therefore, the availability of small-molecule inhibitors targeting this pathway would offer a new chemotherapeutic strategy...
Autores principales: | Ri, M, Tashiro, E, Oikawa, D, Shinjo, S, Tokuda, M, Yokouchi, Y, Narita, T, Masaki, A, Ito, A, Ding, J, Kusumoto, S, Ishida, T, Komatsu, H, Shiotsu, Y, Ueda, R, Iwawaki, T, Imoto, M, Iida, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3408640/ https://www.ncbi.nlm.nih.gov/pubmed/22852048 http://dx.doi.org/10.1038/bcj.2012.26 |
Ejemplares similares
-
Potent antitumor effects of bevacizumab in a microenvironment-dependent human lymphoma mouse model
por: Mori, F, et al.
Publicado: (2012) -
Lower expression of activating transcription factors 3 and 4 correlates with shorter progression-free survival in multiple myeloma patients receiving bortezomib plus dexamethasone therapy
por: Narita, T, et al.
Publicado: (2015) -
An Expeditious Total Synthesis of 5′-Deoxy-toyocamycin and 5′-Deoxysangivamycin
por: Dong, Xiangyou, et al.
Publicado: (2019) -
Selective CDK9 Inhibition by Natural Compound Toyocamycin in Cancer Cells
por: Pandey, Somnath, et al.
Publicado: (2022) -
NUCLEOLI OF DIPLOID CELL STRAINS : Their Normal Ultrastructure and the Effects of Toyocamycin and Actinomycin D
por: Phillips, Stephanie G., et al.
Publicado: (1971)